Common drug tested to stop dangerous heartbeat after major surgery
NCT ID NCT07287345
Summary
This study is testing if adding the anti-inflammatory drug colchicine to standard care can lower inflammation and prevent new irregular heartbeats (atrial fibrillation) after coronary artery bypass surgery. About 24 adults scheduled for this surgery will be randomly assigned to receive either colchicine or a placebo pill, with neither patients nor doctors knowing who gets which. The small pilot study will measure inflammation levels, track irregular heartbeat occurrences, and monitor for side effects to help plan a larger future trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLCHICINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kentucy
RECRUITINGLexington, Kentucky, 40536, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.